Rao, Ashwin
Rule, Jody A.
Cerro-Chiang, Giuliana
Stravitz, Richard T.
McGuire, Brendan M.
Lee, Goo
Fontana, Robert J.
Lee, William M. http://orcid.org/0000-0002-2783-5441
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (Grant No. U-01 58369)
Article History
Received: 22 November 2021
Accepted: 18 April 2022
First Online: 11 May 2022
Declarations
:
: WML serves as a consultant for Affibody, Genentech, Forma, Karuna, SeaGen, Cortexyme, Pfizer, and Alnylam. He receives research funding to conduct clinical trials from Merck, BMS, Intercept, Novo Nordisk, Eiger, and Alexion. RJF receives research support from AbbVie, Gilead, and Bristol Myers Squibb and has consulted for Sanofi. RTS receives funding from IL and Exalenz. AR, JR, GC, BMM, and GL have no financial disclosures to report. All authors certify that they have no non-financial interests (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Free to read: This content has been made available to all.